Stem Cell Manufacturing Industry Report 2024, Featuring Profiles of Anterogen, Becton, Dickinson and Company, Bio-Rad Laboratories, Cellular Dynamics International, Holostem Terapie Avanzate and More
December 03, 2024 08:24 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Manufacturing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell...
Stem Cell Therapy Strategic Business Report 2024 - Allogeneic Stem Cell Therapy Segment is Expected to Reach US$1 Billion by 2030 with a CAGR of a 16.7%
December 02, 2024 04:23 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell Therapy was...
Cancer Stem Cells Market Projected to Reach $3.1 Billion by 2030, Fueled by Advances in Stem Cell Based Cancer Therapies
December 08, 2023 08:03 ET
|
Research and Markets
Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The "Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms...
Stem Cell Technologies and Applications Market Report 2022-2032: Rise in Stem Cell Clinical Trials Bodes Well for Growth
June 09, 2023 05:23 ET
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Stem Cell Technologies and Applications Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.The Stem Cell Technologies...
Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions
October 27, 2015 21:07 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that the United States Patent and Trademark Office (USPTO) has granted a...